| Drs. Tucker-kudrna-holec-young Eye Care Centre Llp | |
|
2020 Jackson Blvd Ste 1, Rapid City, SD 57702-3483 | |
| (605) 342-0777 | |
| (605) 342-7282 |
| Full Name | Drs. Tucker-kudrna-holec-young Eye Care Centre Llp |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 2020 Jackson Blvd Ste 1, Rapid City, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225090459 | NPI | - | NPPES |
| 520 | Other | SD | DR KUDRNA STATE LICENSE |
| 626 | Other | SD | DR. YOUNG STATE LICENSE |
| 9201280 | Medicaid | SD | |
| 9202543 | Medicaid | SD | |
| 9203593 | Medicaid | SD | |
| 9200363 | Medicaid | SD | |
| 587 | Other | SD | DR HOLEC STATE LICENSE |
| 0040353 | Other | SD | WELLMARK BCBS ID NUMBER |
| 459 | Other | SD | DR TUCKER STATE LICENSE |
| S40353 | Other | SD | MEDICARE PTAN |
| Provider Name | Falon S Young |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1295765055 PECOS PAC ID: 6305849977 Enrollment ID: I20060821000424 |
News Archive
AcademyHealth today announced that an experimental application to track patients' care experiences in real time is the winner of the Relevant Evidence to Advance Care and Health (REACH) Developer Challenge.
Phase 1 clinical trial can be initiated for ASM8, a new inhalation drug that is designed to treat asthma through a unique approach by attacking multiple mediators of the inflammatory mechanism rather than the single mediator approach of current therapies.
In new research appearing in this month's issue of the journal Nature Immunology, Roy Curtiss, director of the Center for Infectious Diseases and Vaccinology at the Biodesign Institute at Arizona State University, along with international collaborators, investigates the coordination of a particular type of immune response, involving the release of of IFN-λ- a cell-signaling protein molecule known as a cytokine.
The Texas Legislature in the new session that begins on Tuesday will consider two bills (SB 110, HB 215) that would require girls entering the sixth grade to receive Merck's human papillomavirus vaccine Gardasil, KENS 5 Eyewitness News/San Antonio Express-News reports.
› Verified 2 days ago
| Provider Name | William J Holec |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1720146095 PECOS PAC ID: 7618925827 Enrollment ID: I20100325001084 |
News Archive
AcademyHealth today announced that an experimental application to track patients' care experiences in real time is the winner of the Relevant Evidence to Advance Care and Health (REACH) Developer Challenge.
Phase 1 clinical trial can be initiated for ASM8, a new inhalation drug that is designed to treat asthma through a unique approach by attacking multiple mediators of the inflammatory mechanism rather than the single mediator approach of current therapies.
In new research appearing in this month's issue of the journal Nature Immunology, Roy Curtiss, director of the Center for Infectious Diseases and Vaccinology at the Biodesign Institute at Arizona State University, along with international collaborators, investigates the coordination of a particular type of immune response, involving the release of of IFN-λ- a cell-signaling protein molecule known as a cytokine.
The Texas Legislature in the new session that begins on Tuesday will consider two bills (SB 110, HB 215) that would require girls entering the sixth grade to receive Merck's human papillomavirus vaccine Gardasil, KENS 5 Eyewitness News/San Antonio Express-News reports.
› Verified 2 days ago
| Provider Name | Lynn R Tucker |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1245398510 PECOS PAC ID: 9830170323 Enrollment ID: I20100325001108 |
News Archive
AcademyHealth today announced that an experimental application to track patients' care experiences in real time is the winner of the Relevant Evidence to Advance Care and Health (REACH) Developer Challenge.
Phase 1 clinical trial can be initiated for ASM8, a new inhalation drug that is designed to treat asthma through a unique approach by attacking multiple mediators of the inflammatory mechanism rather than the single mediator approach of current therapies.
In new research appearing in this month's issue of the journal Nature Immunology, Roy Curtiss, director of the Center for Infectious Diseases and Vaccinology at the Biodesign Institute at Arizona State University, along with international collaborators, investigates the coordination of a particular type of immune response, involving the release of of IFN-λ- a cell-signaling protein molecule known as a cytokine.
The Texas Legislature in the new session that begins on Tuesday will consider two bills (SB 110, HB 215) that would require girls entering the sixth grade to receive Merck's human papillomavirus vaccine Gardasil, KENS 5 Eyewitness News/San Antonio Express-News reports.
› Verified 2 days ago
| Provider Name | Gaylene R Kudrna |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1063570349 PECOS PAC ID: 8921089418 Enrollment ID: I20100325001111 |
News Archive
AcademyHealth today announced that an experimental application to track patients' care experiences in real time is the winner of the Relevant Evidence to Advance Care and Health (REACH) Developer Challenge.
Phase 1 clinical trial can be initiated for ASM8, a new inhalation drug that is designed to treat asthma through a unique approach by attacking multiple mediators of the inflammatory mechanism rather than the single mediator approach of current therapies.
In new research appearing in this month's issue of the journal Nature Immunology, Roy Curtiss, director of the Center for Infectious Diseases and Vaccinology at the Biodesign Institute at Arizona State University, along with international collaborators, investigates the coordination of a particular type of immune response, involving the release of of IFN-λ- a cell-signaling protein molecule known as a cytokine.
The Texas Legislature in the new session that begins on Tuesday will consider two bills (SB 110, HB 215) that would require girls entering the sixth grade to receive Merck's human papillomavirus vaccine Gardasil, KENS 5 Eyewitness News/San Antonio Express-News reports.
› Verified 2 days ago
| Provider Name | Sarah P Houdek |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1558974964 PECOS PAC ID: 9133546187 Enrollment ID: I20200904001587 |
News Archive
AcademyHealth today announced that an experimental application to track patients' care experiences in real time is the winner of the Relevant Evidence to Advance Care and Health (REACH) Developer Challenge.
Phase 1 clinical trial can be initiated for ASM8, a new inhalation drug that is designed to treat asthma through a unique approach by attacking multiple mediators of the inflammatory mechanism rather than the single mediator approach of current therapies.
In new research appearing in this month's issue of the journal Nature Immunology, Roy Curtiss, director of the Center for Infectious Diseases and Vaccinology at the Biodesign Institute at Arizona State University, along with international collaborators, investigates the coordination of a particular type of immune response, involving the release of of IFN-λ- a cell-signaling protein molecule known as a cytokine.
The Texas Legislature in the new session that begins on Tuesday will consider two bills (SB 110, HB 215) that would require girls entering the sixth grade to receive Merck's human papillomavirus vaccine Gardasil, KENS 5 Eyewitness News/San Antonio Express-News reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Drs. Tucker-kudrna-holec-young Eye Care Centre Llp 2020 Jackson Blvd Ste 1, Rapid City, SD 57702-3483 Ph: (605) 342-0777 | Drs. Tucker-kudrna-holec-young Eye Care Centre Llp 2020 Jackson Blvd Ste 1, Rapid City, SD 57702-3483 Ph: (605) 342-0777 |
News Archive
AcademyHealth today announced that an experimental application to track patients' care experiences in real time is the winner of the Relevant Evidence to Advance Care and Health (REACH) Developer Challenge.
Phase 1 clinical trial can be initiated for ASM8, a new inhalation drug that is designed to treat asthma through a unique approach by attacking multiple mediators of the inflammatory mechanism rather than the single mediator approach of current therapies.
In new research appearing in this month's issue of the journal Nature Immunology, Roy Curtiss, director of the Center for Infectious Diseases and Vaccinology at the Biodesign Institute at Arizona State University, along with international collaborators, investigates the coordination of a particular type of immune response, involving the release of of IFN-λ- a cell-signaling protein molecule known as a cytokine.
The Texas Legislature in the new session that begins on Tuesday will consider two bills (SB 110, HB 215) that would require girls entering the sixth grade to receive Merck's human papillomavirus vaccine Gardasil, KENS 5 Eyewitness News/San Antonio Express-News reports.
› Verified 2 days ago
J Geoffrey Slingsby Md Pc Optometrist Medicare: Medicare Enrolled Practice Location: 240 Minnesota St, Rapid City, SD 57701 Phone: 605-719-9499 Fax: 605-719-9509 | |
Dr. Gaylene R. Kudrna, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2020 Jackson Blvd, Suite 1, Rapid City, SD 57702 Phone: 605-342-0777 Fax: 605-342-7282 | |
Cary S. Feldman, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 808 Mount Rushmore Rd, Rapid City, SD 57701 Phone: 605-719-9489 | |
Dr. Megan Renee Rotella, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2200 N Maple Ave, Attn: Jcpenney Optical, Rapid City, SD 57701 Phone: 605-341-7832 Fax: 605-399-9319 | |
Ross English, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 925 Eglin St, Rapid City, SD 57701 Phone: 605-342-1213 | |
Eye Works, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 685 Mountain View Rd, Rapid City, SD 57702 Phone: 605-718-7550 | |
Dr. Jess Moser, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2800 3rd St, Rapid City, SD 57701 Phone: 605-719-3107 Fax: 605-719-3321 |